The activity of ANT is severely impaired by the tau-derived peptide NH2-26–44, as demonstrated in primary cerebellar granule cell cultures (Atlante et al. 2008) and postmortem AD brain tissue (Amadoro et al. 2012). The gene discussed is MAPT; the disease is Alzheimer disease.